Get to Know This Progressively Degenerative Disease
The sooner Friedreich’s ataxia (FA) is confirmed with the right genetic test, the sooner you can guide your patients to optimal supportive care.3
FA is a multisystem disease, so it is critical to connect patients and their families to the multidisciplinary support they need.4
The modified Friedreich’s Ataxia Rating Scale (mFARS) is a clinically validated neurological assessment and provides a detailed evaluation of a patient’s status. The mFARS can provide a clear picture of the relentless progression of FA and its severe impact on patient function.5
Stay ConnectedSign up to receive the latest news and resources for FA.
References: 1. National Institute of Neurological Disorders and Stroke. Friedreich Ataxia Fact Sheet. November 15, 2021. Accessed March 16, 2022. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Friedreichs-Ataxia-Fact-Sheet. 2. Schulz JB, Boesch S, Bürk K, et al. Diagnosis and treatment of Friedreich ataxia: a European perspective. Nat Rev Neurol. 2009;5(4):222-234. 3. Fogel BL, Perlman S. Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. Lancet Neurol. 2007;6(3):245-257. 4. de Silva RN, Vallortigara J, Greenfield J, Hunt B, Giunti P, Hadjivassiliou M. Diagnosis and management of progressive ataxia in adults. Pract Neurol. 2019;19(3):196-207. 5. Rummey C, Corben LA, Delatycki MB, et al. Psychometric properties of the Friedreich Ataxia Rating Scale. Neurol Genet. 2019;5(6):371.
You are now leaving ThinkFA.com